Janus Henderson Group PLC Gossamer Bio, Inc. Transaction History

Janus Henderson Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.74 - $12.87 $1 - $12	1 Added 0.01%	10,123 $21,000
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $310 - $639	-43 Reduced 0.42%	10,122 $121,000
Q2 2022 Aug 15, 2022	BUY	$5.97 - $9.97 $441 - $737	74 Added 0.73%	10,165 $85,000
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $33 - $49	4 Added 0.04%	10,091 $87,000
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $102,080 - $141,924	10,087 New	10,087 $114,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $81.7M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.